相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma
Nicholas C. Wolff et al.
ONCOTARGET (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Adjuvant Therapy for Renal Cell Carcinoma
Alvaro Pinto
CLINICAL GENITOURINARY CANCER (2014)
The Apoptosis Repressor with a CARD Domain (ARC) Gene Is a Direct Hypoxia-Inducible Factor 1 Target Gene and Promotes Survival and Proliferation of VHL-Deficient Renal Cancer Cells
Olga V. Razorenova et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc
C. Zhang et al.
ONCOGENE (2014)
Antitumoral effect of a selective Rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in mice
Derya Isler et al.
PHARMACOLOGICAL REPORTS (2014)
Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells
Daniele M. Gilkes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Rho-kinase: regulation, (dys) function, and inhibition
Ehsan Amin et al.
BIOLOGICAL CHEMISTRY (2013)
Regulation of autophagosome formation by Rho kinase
Andrzej Mleczak et al.
CELLULAR SIGNALLING (2013)
Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment
Jianjian Shi et al.
CELL DEATH & DISEASE (2013)
Axitinib for the Management of Metastatic Renal Cell Carcinoma
Bernard Escudier et al.
Drugs in research & development (2013)
RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer
Ronil A. Patel et al.
CANCER RESEARCH (2012)
State of the Science: An Update on Renal Cell Carcinoma
Eric Jonasch et al.
MOLECULAR CANCER RESEARCH (2012)
Lack of a Functional VHL Gene Product Sensitizes Renal Cell Carcinoma Cells to the Apoptotic Effects of the Protein Synthesis Inhibitor Verrucarin A
Girma M. Woldemichael et al.
NEOPLASIA (2012)
The roles of VHL-dependent ubiquitination in signaling and cancer
Qing Zhang et al.
FRONTIERS IN ONCOLOGY (2012)
ROCK1 as a Potential Therapeutic Target in Osteosarcoma
Xianzhe Liu et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2011)
Harnessing synthetic lethal interactions in anticancer drug discovery
Denise A. Chan et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration
Olga V. Razorenova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors
Robert J. Motzer et al.
CANCER (2010)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Activating ROCK1 somatic mutations in human cancer
P. A. Lochhead et al.
ONCOGENE (2010)
Inhibition of Rho-Associated Kinase Signaling Prevents Breast Cancer Metastasis to Human Bone
Sijin Liu et al.
CANCER RESEARCH (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Resistance to targeted therapy in renal-cell carcinoma
Brian I. Rini et al.
LANCET ONCOLOGY (2009)
VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy
C. Lance Cowey et al.
CURRENT ONCOLOGY REPORTS (2009)
Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma
Hideyuki Abe et al.
BIOMEDICAL RESEARCH-TOKYO (2008)
Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice
S. Y. Inan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma
John D. Gordan et al.
CANCER CELL (2008)
A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy
Sandra Turcotte et al.
CANCER CELL (2008)
The VHL tumor suppressor and HIF: insights from genetic studies in mice
P. P. Kapitsinou et al.
CELL DEATH AND DIFFERENTIATION (2008)
Fasudil-induced hypoxia-inducible factor-1 alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells
Keiko Takata et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen
Archana Bommi-Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Rho kinase (ROCK) inhibitors
Dames K. Liao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells
Patrick D. Sutphin et al.
CANCER RESEARCH (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc
Yusuke Mizukami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inhibition of rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection
Y Rikitake et al.
STROKE (2005)
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1)
AE Greijer et al.
JOURNAL OF PATHOLOGY (2005)
Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1
OV Razorenova et al.
GENE (2005)
Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer
T Kamai et al.
CLINICAL CANCER RESEARCH (2004)
HIF-1α mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma
S Turcotte et al.
JOURNAL OF CELL SCIENCE (2003)
Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α
DA Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction
K Nagatoya et al.
KIDNEY INTERNATIONAL (2002)
分享论文
